10x Genomics

Compliant

Under AAOIFI Standard 21, 10x Genomics is compliant. Its core business is permissible and its interest-bearing debt is below 30% of market cap.

TickerTXG

ExchangeNASDAQ

SectorSingle-Cell Sequencing Tools

Full ratios for 10x Genomics (impure revenue, debt and interest-bearing deposits under all four standards) are being added. Until then this page shows the screening verdict only. See the methodology for how each test works. Purindex publishes this screening to help people understand what they own. It does not recommend buying, selling or holding 10x Genomics or any other security.